- Home
- SABS vs IINN Comparison
SABS vs IINN Comparison
Compare SABS & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- IINN
- Stock Information
- Founded
- SABS 2014
- IINN 2018
- Country
- SABS United States
- IINN Israel
- Employees
- SABS N/A
- IINN N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- IINN Medical/Dental Instruments
- Sector
- SABS Health Care
- IINN Health Care
- Exchange
- SABS Nasdaq
- IINN Nasdaq
- Market Cap
- SABS 23.9M
- IINN 25.9M
- IPO Year
- SABS N/A
- IINN 2021
- Fundamental
- Price
- SABS $3.34
- IINN $1.00
- Analyst Decision
- SABS Strong Buy
- IINN
- Analyst Count
- SABS 5
- IINN 0
- Target Price
- SABS $12.40
- IINN N/A
- AVG Volume (30 Days)
- SABS 83.3K
- IINN 123.1K
- Earning Date
- SABS 11-06-2024
- IINN 08-15-2024
- Dividend Yield
- SABS N/A
- IINN N/A
- EPS Growth
- SABS N/A
- IINN N/A
- EPS
- SABS N/A
- IINN N/A
- Revenue
- SABS $1,512,723.00
- IINN N/A
- Revenue This Year
- SABS N/A
- IINN N/A
- Revenue Next Year
- SABS N/A
- IINN N/A
- P/E Ratio
- SABS N/A
- IINN N/A
- Revenue Growth
- SABS N/A
- IINN N/A
- 52 Week Low
- SABS $2.16
- IINN $0.76
- 52 Week High
- SABS $7.70
- IINN $2.49
- Technical
- Relative Strength Index (RSI)
- SABS 48.06
- IINN 19.59
- Support Level
- SABS $2.75
- IINN $1.32
- Resistance Level
- SABS $4.30
- IINN $1.28
- Average True Range (ATR)
- SABS 0.51
- IINN 0.06
- MACD
- SABS 0.03
- IINN -0.03
- Stochastic Oscillator
- SABS 26.11
- IINN 1.63
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.